Titre : | Emergency Department Visits for Antiviral Adverse Events During the 2009 H1 N1 Influenza Pandemic. (2011) |
Auteurs : | Maribeth-C LOVEGROVE ; Daniel-S BUDNITZ ; Elizabeth CRANE ; HALES (Craig-M) : USA. Centers for Disease Control and Prevention. Office of Surveillance. Epidemiology. And Laboratory Services. Atlanta. GA. ; Kathy PONELEIT ; Nadine SHEHAB ; Centers for Disease Control and Prevention. National Center for Emerging and Zoonotic Infectious Diseases. Division of Healthcare Quality Promotion. Atlanta. GA. USA ; Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. USA |
Type de document : | Article |
Dans : | Public health reports (vol. 126, n° 3, 2011) |
Pagination : | 312-317 |
Langues: | Anglais |
Mots-clés : | Service urgence ; Médicament antiviral ; Complication ; Pharmacovigilance ; Accident médicamenteux ; Médicament ; Effet secondaire ; Monde ; Virose ; Infection |
Résumé : | [BDSP. Notice produite par INIST-CNRS GpqmkR0x. Diffusion soumise à autorisation]. The 2009 pandemic influenza A (H 1 N 1) outbreak was associated with an increased use of antiviral agents and highlighted the role of population-based monitoring for related adverse drug events (ADEs). An ongoing, nationally representative emergency department-based surveillance system was used to identify and characterize ADEs during the pandemic. Active surveillance for ADEs successfully provided timely, population-based data during the pandemic. Increases in antiviral ADEs paralleled increases in prescribing. Type and severity of ADEs were similar across all seasons. |